Walgreens Boots Alliance, Inc. WBA it is expected to release earnings results for the second quarter, before the opening bell on March 28, 2024.
Analysts expect the Deerfield, Ill.-based company to report quarterly earnings of 82 cents a share, down from $1.16 a share in the same period a year ago. Walgreens is expected to report quarterly revenue of $35.86 billion, according to data from Benzinga Pro.
Walgreens has reportedly taken legal action against a nearly $1 billion arbitration award issued to telehealth provider PWNHealth in a contract dispute.
Walgreens shares gained 2.5% to close at $21.02 on Wednesday.
Benzinga readers can access the latest analyst ratings at Analyst stock ratings page. Readers can sort by stock title, company name, analyst firm, rating change or other variables.
Let’s look at how Benzinga is more accurate analysts rated the company in the recent period.
- Morgan Stanley analyst Erin Wright maintained an Underweight rating and cut the price target from $22 to $21 on March 26, 2024. This analyst has an accuracy rate of 77%.
- RBC capital Analyst Ben Hendrix maintained his Sector Perform rating and cut his price target from $29 to $26 on October 13, 2023. This analyst has an accuracy rate of 68%.
- Fiduciary Securities Analyst David Macdonald maintained a Hold rating and cut the price target from $30 to $25 on October 11, 2023. This analyst has an accuracy rate of 73%.
- Mizuho analyst Ann Hynes maintained a Neutral rating and cut her price target from $31 to $25 on October 10, 2023. This analyst has an accuracy rate of 76%.
- German bank George Hill maintained a Hold rating and lowered the price target from $34 to $27 on September 22, 2023. This analyst has an accuracy rate of 60%.
Read this next: Jim Cramer says not to sell this beauty brand, believes KKR and Blackstone ‘can make more money’